Mary Jo O’Sullivan
Biographic Data
| ID | 5490914 |
|---|---|
| NAME | Mary Jo O’Sullivan |
| GIVEN NAMES | Mary Jo |
| FAMILY NAME | O’Sullivan |
| SIGNATURE | O’SULLIVAN M J |
| AFFILIATIONS | University of Miami |
| VERIFIED | No |
| TOTAL WORKS | 5 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 5 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 1994 |
| LATEST PUBLICATION YEAR | 2010 |
| H-INDEX | 0 |
Factors Associated with Declining a Rapid Human Immunodeficiency Virus Test in Labor and Delivery
Depressive Symptoms in the Immediate Postpartum Period Among Hispanic Women in Three U.S. Cities
Life Stress and Cervical Squamous Intraepithelial Lesions in Women With Human Papillomavirus and Human Immunodeficiency Virus
OBJECTIVE: Human immunodeficiency virus (HIV)-infected women are at risk for cervical intraepithelial neoplasia (CIN) and cancer due to impaired immunosurveillance over human papillomavirus (HPV) infection. Life stress has been implicated in immune decrements in HIV-infected individuals and therefore may contribute to CIN progression over time. The purpose of this study was to determine whether life stress was associated with progression and/or p…
Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine Treatment
BACKGROUND AND METHODS: Maternal-infant transmission is the primary means by which young children become infected with human immunodeficiency virus type 1 (HIV). We conducted a randomized, double-blind, placebo-controlled trial of the efficacy and safety of zidovudine in reducing the risk of maternal-infant HIV transmission. HIV-infected pregnant women (14 to 34 weeks' gestation) with CD4+ T-lymphocyte counts above 200 cells per cubic millimeter …
Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type I with Zidovudine Treatment
No prominent works on this page.
Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine Treatment
BACKGROUND AND METHODS: Maternal-infant transmission is the primary means by which young children become infected with human immunodeficiency virus type 1 (HIV). We conducted a randomized, double-blind, placebo-controlled trial of the efficacy and safety of zidovudine in reducing the risk of maternal-infant HIV transmission. HIV-infected pregnant women (14 to 34 weeks' gestation) with CD4+ T-lymphocyte counts above 200 cells per cubic millimeter …
Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type I with Zidovudine Treatment
Life Stress and Cervical Squamous Intraepithelial Lesions in Women With Human Papillomavirus and Human Immunodeficiency Virus
OBJECTIVE: Human immunodeficiency virus (HIV)-infected women are at risk for cervical intraepithelial neoplasia (CIN) and cancer due to impaired immunosurveillance over human papillomavirus (HPV) infection. Life stress has been implicated in immune decrements in HIV-infected individuals and therefore may contribute to CIN progression over time. The purpose of this study was to determine whether life stress was associated with progression and/or p…
Depressive Symptoms in the Immediate Postpartum Period Among Hispanic Women in Three U.S. Cities
Factors Associated with Declining a Rapid Human Immunodeficiency Virus Test in Labor and Delivery
Medicine (5 works) · HIV/AIDS Research and Interventions (3 works) · Immunology (3 works) · Pregnancy (3 works) · HIV Research and Treatment (2 works) · HIV/AIDS drug development and treatment (2 works) · Human immunodeficiency virus (HIV (2 works) · Immunology (2 works) · Internal Medicine (2 works) · Nursing (2 works)